Astria Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Astria Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Astria Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$29M, a 43.4% decline year-over-year.
  • Astria Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$116M, a 84% decline year-over-year.
  • Astria Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$83M, a 55.2% decline from 2022.
  • Astria Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$53.5M, a 72.6% increase from 2021.
  • Astria Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$195M, a 421% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$83M -$29.5M -55.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-04
2022 -$53.5M +$141M +72.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-04
2021 -$195M -$158M -421% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 -$37.4M -$10.3M -38.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 -$27.1M -$717K -2.72% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-19
2018 -$26.4M +$723K +2.67% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 -$27.1M +$8.46M +23.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
2016 -$35.6M -$3.9M -12.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 -$31.7M -$9.98M -46% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 -$21.7M -$3.56M -19.7% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$18.1M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.